CONSTANT LEVERAGE LONG - UCB | Market Closed - Euronext Paris 17:30:02 13/06/2024 BST | ||
| 8.045 EUR | +2.03% |
|
| Current month | +30.71% | ||
| 1 month | +61.84% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
UCB
| Date | Price | Change |
|---|---|---|
| 13/06/24 | 8.045 | +2.03% |
| 12/06/24 | 7.885 | +15.62% |
| 11/06/24 | 6.82 | +3.41% |
| 10/06/24 | 6.595 | -0.23% |
| 07/06/24 | 6.61 | +1.38% |
Real-time Euronext Paris
Last update June 13, 2024 at 05:30 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | UCB |
| Issuer | 
BNP Paribas
|
| L5PFB | |
| ISIN | FRBNPP03GNB3 |
| Date issued | 21/01/2022 |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 27.08 € |
|---|---|
| Lowest since issue | 0.333 € |
| Spread | 0.39 € |
| Spread % | 4.73% |
Company Profile
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Sector
-
Consensus: UCB
Sell
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
136
EUR
Average target price
135
EUR
Spread / Average Target
-0.72%
- Stock Market
- Certificates
- L5PFB Certificat